Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) Gross Margin (2016 - 2026)

Healthequity has reported Gross Margin over the past 14 years, most recently at 68.19% for Q1 2026.

  • For Q1 2026, Gross Margin rose 756.0% year-over-year to 68.19%; the TTM value through Jan 2026 reached 69.52%, up 474.0%, while the annual FY2026 figure was 69.52%, 474.0% up from the prior year.
  • Gross Margin for Q1 2026 was 68.19% at Healthequity, down from 70.79% in the prior quarter.
  • Over five years, Gross Margin peaked at 71.38% in Q3 2025 and troughed at 51.95% in Q1 2022.
  • A 5-year average of 62.75% and a median of 62.27% in 2023 define the central range for Gross Margin.
  • Biggest five-year swings in Gross Margin: crashed -198bps in 2022 and later skyrocketed 756bps in 2026.
  • Year by year, Gross Margin stood at 58.92% in 2022, then rose by 8bps to 63.87% in 2023, then increased by 3bps to 65.58% in 2024, then rose by 8bps to 70.79% in 2025, then fell by -4bps to 68.19% in 2026.
  • Business Quant data shows Gross Margin for HQY at 68.19% in Q1 2026, 70.79% in Q4 2025, and 71.38% in Q3 2025.